Nine states are showing a high probability of legalizing adult-use cannabis by 2030, while another nine are likely to legalize medical weed. Read More
Analyst Articles
Our editorial director interviews financial guru Robert Rapier about the investment opportunities and risks in the year ahead. Read More
The stock market has become a minefield, as companies that beat earnings expectations see their shares drop anyway. Read More
International markets are rebounding, which makes overseas dividend payers attractive. This global dividend ETF is flashing “buy.” Read More
Lingering inflation makes it likely that the Fed’s tightening cycle will stay aggressive for longer, a dynamic that's weighing on equities. Read More
Here’s a round-up of the latest developments of interest to investors in the cannabis and psychedelics industries. Read More
Here’s a look at the biggest, most appealing investment themes in the technology sector for this year...and beyond. Read More
In this question-and-answer session, we discuss profitable opportunities and portfolio protection with a renowned financial advisor. Read More
Our nation’s lawmakers may be derelict in their sworn duties, but inflation remains active. Here’s a look at the latest price data. Read More
U.S. regulators are making it easier to lend to hemp businesses. That’s a huge break for cannabis investors. Read More